| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 1,502 | 2,749 |
| Depreciation | 2,966 | 1,958 |
| Amortization of intangible assets | 1,226 | 815 |
| Amortization of financing fees | 199 | 133 |
| Stock-based compensation | 698 | 462 |
| Deferred income taxes | -124 | -609 |
| Accounts receivable | 1,435 | 2,702 |
| Inventories | 1,127 | -1,102 |
| Prepaid expenses and other assets | -2,404 | -4,577 |
| Accounts payable and other liabilities | 2,944 | -400 |
| Net cash provided by operating activities | 9,501 | 9,303 |
| Proceeds from sale of equipment | 4 | - |
| Purchases of property, plant and equipment | 2,990 | 1,995 |
| Net cash used in investing activities | -2,986 | -1,995 |
| Payments on credit facilities-Revolving Credit Facility | -4,063 | -3,375 |
| Debt issuance costs | 24 | 24 |
| Proceeds from exercise of stock options | 98 | 61 |
| Net cash used in financing activities | -3,989 | -3,338 |
| Effect of exchange rate changes on cash | -120 | 117 |
| Increase (decrease) in cash | 2,406 | 4,087 |
| Cash and cash equivalents at beginning of period | 6,854 | - |
| Cash and cash equivalents at end of period | 9,260 | - |
ULTRALIFE CORP (ULBI)
ULTRALIFE CORP (ULBI)